Patents Assigned to Research Genetics, Inc.
  • Nucleotide sequence encoding oligodendrocyte-specific protein
    Patent number: 6150136
    Abstract: A protein consisting essentially of purified oligodendrocyte-specific protein or purified biologically active variants thereof, or a combination of purified oligodendrocyte-specific protein and biologically active variants thereof. A purified and isolated peptide having the sequence Ala-Lys-Tyr-Arg-Arg-Ala-Gln-Leu-Ala-Gly, residues 115-124 of SEQ ID NO:2.
    Type: Grant
    Filed: May 22, 1998
    Date of Patent: November 21, 2000
    Assignees: The Regents of the University of California, Research Genetics, Inc.
    Inventors: Jeff M. Bronstein, Robert S. Seitz, Roger L. Lallone
  • Oligodendrocyte-specific protein and method for diagnosing and treating disease
    Patent number: 5756300
    Abstract: A protein consisting essentially of purified oligodendrocyte-specific protein or purified biologically active variants thereof, or a combination of purified oligodendrocyte-specific protein and biologically active variants thereof. A purified and isolated peptide having the sequence Ala-Lys-Tyr-Arg-Arg-Ala-Gln-Leu-Ala-Gly residues 115-124 of SEQ ID NO:2. A device for identifying an epitope region of a peptide, protein, or protein homologue of interest comprising a polypropylene membrane having a plurality of sequentially oriented peptide spots, each spot containing a peptide having an amino acid sequence where the amino acid sequences of the peptides on the peptide spots sequentially progress through the amino acid sequence of the peptide, protein, or protein homologue of interest. A method of diagnosing multiple sclerosis and a method of treating multiple sclerosis.
    Type: Grant
    Filed: November 14, 1995
    Date of Patent: May 26, 1998
    Assignees: Research Genetics, Inc., University of California at Los Angeles
    Inventors: Robert S. Seitz, Roger L. Lallone, Jeff M. Bronstein